Key indicators: measuring the Alliance's progress against its four strategic goals

VACCINESCOUNTRY UPTAKEFRONTLOADINGMARKET-SHAPING

GAVI-funded vaccines have prevented 5.4m future deaths

By the end of 2009, GAVI had helped prevent 5.4 million future deaths through routine immunisation against hepatitis B, Haemophilus influenzae type b (Hib) and pertussis (whooping cough), and one-off investments in immunisation against measles, polio and yellow fever. Many more have been protected against debilitating illness and disability.

Source: these estimates and projections are produced by the WHO Department of Immunization, Vaccines and Biologicals, based on the most up to date data and models available as of January 2010; for yellow fever figure: Global Alert and Response and Department of Immunization, Vaccines and Biologicals, WHO; for polio figure: Polio Eradication Initiative, WHO.

Immunisation coverage has climbed steadily in the last decade. Coverage for three doses of the diphtheria-tetanus-pertussis vaccine (DTP3) in GAVI-eligible countries in 2009 is projected at 79% - the highest level ever seen in the developing world. From 2000 to 2009, more than 257 million children have been immunised with GAVI-funded vaccines.

Source: Source: WHO-UNICEF coverage estimates for 1980-2008, as of July 2009; WHO ICE-T coverage projections for 2009-2010, as of September 2009; World Population Prospects, the 2008 revision. New York, United Nations, 2009; (surviving infants).